JAMA oncology, 2374-2437

Journal

Related Publications
  1. Detection of TP53 R249 Mutation in Iranian Patients with Pancreatic Cancer

    Mohamadkhani, A., Naderi, E., Sharafkhah, M., Fazli, H. R., Moradzadeh, M. & Pourshams, A., 2013, In : JAMA oncology. 2013, 6 p., 738915.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk

    Familial MRI Screening (FaMRIsc) Study group, Geuzinge, H. A., Obdeijn, I-M., Rutgers, E. J. T., Saadatmand, S., Mann, R. M., Oosterwijk, J. C., Tollenaar, R. A. E. M., de Roy van Zuidewijn, D. B. W., Lobbes, M. B. I., van 't Riet, M., Hooning, M. J., Ausems, M. G. E. M., Loo, C. E., Wesseling, J., Luiten, E. J. T., Zonderland, H. M., Verhoef, C., Heijnsdijk, E. A. M., Tilanus-Linthorst, M. M. A. & de Koning, H. J., Sep-2020, In : JAMA oncology. 6, 9, p. 1381-1389 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer-Reply

    Steenbruggen, T. G., Steggink, L. C. & Sonke, G. S., 4-Jun-2020, In : JAMA oncology. 6, 8, p. 1299-1300 12 p.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  4. High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes 20-Year Follow-up of a Phase 3 Randomized Clinical Trial: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial

    Steenbruggen, T. G., Steggink, L. C., Seynaeve, C. M., van der Hoeven, J. J. M., Hooning, M. J., Jager, A., Konings, I. R., Kroep, J. R., Smit, W. M., Tjan-Heijnen, V. C. G., van der Wall, E., Bins, A. D., Linn, S. C., Schaapveld, M., Jacobse, J. N., van Leeuwen, F. E., Schröder, C. P., van Tinteren, H., de Vries, E. G. E., Sonke, G. S. & Gietema, J. A., Apr-2020, In : JAMA oncology. 6, 4, p. 528-534 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Correcting the Conclusion in a Study of Frameworks for Measurement of Absolute or Relative Clinical Survival Benefit

    Dafni, U., Cherny, N. I. & de Vries, E. G. E., Dec-2019, In : JAMA oncology. 5, 12, p. 1807 1 p.

    Research output: Contribution to journalLetterAcademicpeer-review

View all (14) »

ID: 37132924